OraSure Research Development vs Total Operating Expenses Analysis
OSUR Stock | USD 4.08 0.03 0.73% |
OraSure Technologies financial indicator trend analysis is much more than just breaking down OraSure Technologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether OraSure Technologies is a good investment. Please check the relationship between OraSure Technologies Research Development and its Total Operating Expenses accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OraSure Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OraSure Stock, please use our How to Invest in OraSure Technologies guide.
Research Development vs Total Operating Expenses
Research Development vs Total Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of OraSure Technologies Research Development account and Total Operating Expenses. At this time, the significance of the direction appears to have almost identical trend.
The correlation between OraSure Technologies' Research Development and Total Operating Expenses is 0.91. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of OraSure Technologies, assuming nothing else is changed. The correlation between historical values of OraSure Technologies' Research Development and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of OraSure Technologies are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Research Development i.e., OraSure Technologies' Research Development and Total Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.91 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Research Development
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most indicators from OraSure Technologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into OraSure Technologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in OraSure Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. To learn how to invest in OraSure Stock, please use our How to Invest in OraSure Technologies guide.As of 12/12/2024, Selling General Administrative is likely to drop to about 33 M. In addition to that, Tax Provision is likely to drop to about 1.7 M
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 16.3M | 10.4M | 12.0M | 6.7M | Depreciation And Amortization | 11.7M | 14M | 20.9M | 22.0M |
OraSure Technologies fundamental ratios Correlations
Click cells to compare fundamentals
OraSure Technologies Account Relationship Matchups
High Positive Relationship
High Negative Relationship
OraSure Technologies fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 349.3M | 454.5M | 461.0M | 444.7M | 482.8M | 507.0M | |
Other Current Liab | 17.8M | 18.6M | 28.6M | 21.4M | 19.3M | 20.3M | |
Total Current Liabilities | 32.7M | 46.5M | 68.1M | 70.4M | 39.5M | 41.5M | |
Total Stockholder Equity | 307.1M | 398.6M | 380.5M | 363.6M | 430.7M | 452.2M | |
Property Plant And Equipment Net | 37.3M | 51.9M | 88.2M | 59.4M | 58.3M | 61.2M | |
Net Debt | (70.1M) | (154.7M) | (104.5M) | (71.4M) | (276.9M) | (263.1M) | |
Retained Earnings | (82.5M) | (97.5M) | (120.5M) | (138.4M) | (83.9M) | (88.1M) | |
Accounts Payable | 9.6M | 17.4M | 28.0M | 38.0M | 13.2M | 13.8M | |
Cash | 75.7M | 160.8M | 116.8M | 84.0M | 290.4M | 304.9M | |
Non Current Assets Total | 124.7M | 165.6M | 172.6M | 119.0M | 96.4M | 101.2M | |
Non Currrent Assets Other | 2.3M | 6.6M | 10.5M | 12.4M | 1.2M | 2.0M | |
Cash And Short Term Investments | 156.3M | 209.4M | 153.0M | 110.8M | 290.4M | 304.9M | |
Net Receivables | 36.9M | 38.8M | 45.3M | 70.8M | 40.2M | 42.2M | |
Common Stock Shares Outstanding | 62.2M | 67.5M | 72.0M | 72.5M | 74.4M | 44.7M | |
Liabilities And Stockholders Equity | 349.3M | 454.5M | 461.0M | 444.7M | 482.8M | 507.0M | |
Non Current Liabilities Total | 9.4M | 9.4M | 12.4M | 10.7M | 12.6M | 13.3M | |
Inventory | 23.2M | 31.9M | 53.1M | 96.2M | 47.6M | 50.0M | |
Other Current Assets | 8.1M | 8.8M | 36.9M | 47.8M | 8.3M | 10.3M | |
Other Stockholder Equity | 401.8M | 505.1M | 511.1M | 520.4M | 529.5M | 556.0M | |
Total Liab | 42.2M | 55.9M | 80.5M | 81.1M | 52.2M | 54.8M | |
Property Plant And Equipment Gross | 37.3M | 57.6M | 160.9M | 141.0M | 143.4M | 150.6M | |
Total Current Assets | 224.6M | 288.9M | 288.4M | 325.7M | 386.5M | 405.8M | |
Accumulated Other Comprehensive Income | (12.1M) | (9.1M) | (10.1M) | (18.4M) | (14.9M) | (14.2M) | |
Intangible Assets | 14.7M | 17.9M | 14.3M | 11.7M | 1.2M | 1.1M | |
Short Term Investments | 83.0M | 68.1M | 80.6M | 48.6M | 36.3M | 26.9M | |
Common Stock | 258.1M | 283.4M | 307.1M | 380.5M | 437.6M | 459.5M | |
Other Liab | 3.9M | 4.9M | 12.4M | 1.1M | 1.3M | 2.4M | |
Other Assets | 3.2M | 7.7M | 50.4K | 60.6K | 54.6K | 51.8K | |
Property Plant Equipment | 37.3M | 51.9M | 88.2M | 59.4M | 68.3M | 71.7M | |
Current Deferred Revenue | 3.7M | 4.8M | 2.9M | 2.3M | 1.6M | 1.5M | |
Net Tangible Assets | 256.3M | 340.3M | 325.9M | 316.8M | 364.3M | 221.1M | |
Good Will | 36.2M | 40.4M | 40.3M | 35.1M | 35.7M | 30.4M | |
Capital Surpluse | 401.8M | 505.1M | 511.1M | 520.4M | 598.5M | 429.9M | |
Non Current Liabilities Other | 3.0M | 8.2M | 12.4M | 10.7M | 696K | 661.2K | |
Net Invested Capital | 307.1M | 398.6M | 380.5M | 363.6M | 430.7M | 380.6M |
Pair Trading with OraSure Technologies
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OraSure Technologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OraSure Technologies will appreciate offsetting losses from the drop in the long position's value.Moving against OraSure Stock
0.72 | DXCM | DexCom Inc | PairCorr |
0.68 | DOCS | Doximity | PairCorr |
0.68 | VREX | Varex Imaging Corp | PairCorr |
0.62 | EW | Edwards Lifesciences Corp | PairCorr |
0.6 | OM | Outset Medical | PairCorr |
The ability to find closely correlated positions to OraSure Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OraSure Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OraSure Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OraSure Technologies to buy it.
The correlation of OraSure Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OraSure Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OraSure Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OraSure Technologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OraSure Stock Analysis
When running OraSure Technologies' price analysis, check to measure OraSure Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OraSure Technologies is operating at the current time. Most of OraSure Technologies' value examination focuses on studying past and present price action to predict the probability of OraSure Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OraSure Technologies' price. Additionally, you may evaluate how the addition of OraSure Technologies to your portfolios can decrease your overall portfolio volatility.